Resultados: 4

    Guideline No. 398: progesterone for prevention of spontaneous preterm birth

    J. obstet. gynaecol. Can; 42 (6), 2020
    To assess the benefits and risks of progesterone therapy for women at increased risk of spontaneous preterm birth (SPB) and to make recommendations for the use of progesterone to reduce the risk of SPB and improve postnatal outcomes. To administer or withhold progesterone therapy for women deemed to be a...

    Biomarker tests to help diagnose preterm labour in women with intact membranes

    This guideline covers recommendations on biomarker tests to help diagnose preterm labour in women with intact membranes. The tests are Actim Partus, PartoSure and the Rapid fetal fibronectin (fFN) 10Q Cassette Kit (at thresholds other than 50 nanograms/millilitre)....

    WHO recommendations on interventions to improve preterm birth outcomes

    The primary audience for this guideline includes health-care professionals who are responsible for developing national and local health-care protocols and policies, as well as managers of maternal and child health programmes and policy-makers in all settings. The guideline will also be useful to those di...